Paper41454273
Incidence of different histologic subtype of ovarian cancer in China: a population-based cancer registry study.
Wang Y and 2 others. BMC Womens Health, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Incidence of different histologic subtype of ovarian cancer in China: a population-based cancer registry study. Papers, record 41454273. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41454273
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Incidence of different histologic subtype of ovarian cancer in China: a population-based cancer registry study.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ovarian Neoplasms | Major topic |
| Adenocarcinoma, Clear Cell | Major topic |
| Humans | |
| Female | |
| China | |
| Incidence | |
| Registries | |
| Middle Aged | |
| Adult | |
| Aged | |
| Adenocarcinoma, Mucinous | |
| Carcinoma, Endometrioid | |
| Young Adult | |
| Aged, 80 and over |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32008036 | Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014. | Med Sci Monit | 2020 | https://conductscience.org/library/papers/32008036 | PubMed |
| 2 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 3 | 29890249 | Origins based clinical and molecular complexities of epithelial ovarian cancer. | Int J Biol Macromol | 2018 | https://conductscience.org/library/papers/29890249 | PubMed |
| 4 | 39794860 | Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021. | J Hematol Oncol | 2025 | https://conductscience.org/library/papers/39794860 | PubMed |
| 5 | 38400738 | Association between diet quality and ovarian cancer risk and survival. | J Natl Cancer Inst | 2024 | https://conductscience.org/library/papers/38400738 | PubMed |
| 6 | 27558151 | Ovarian cancer. | Nat Rev Dis Primers | 2016 | https://conductscience.org/library/papers/27558151 | PubMed |
| 7 | 39720606 | Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017. | EClinicalMedicine | 2025 | https://conductscience.org/library/papers/39720606 | PubMed |
| 8 | 33308841 | Diet and ovarian cancer risk: An umbrella review of systematic reviews and meta-analyses of cohort studies. | Clin Nutr | 2021 | https://conductscience.org/library/papers/33308841 | PubMed |
| 9 | 31099893 | Epithelial ovarian cancer: Evolution of management in the era of precision medicine. | CA Cancer J Clin | 2019 | https://conductscience.org/library/papers/31099893 | PubMed |
| 10 | 37452315 | Trends in incidence and mortality for ovarian cancer in China from 1990 to 2019 and its forecasted levels in 30 years. | J Ovarian Res | 2023 | https://conductscience.org/library/papers/37452315 | PubMed |
| 11 | 40327333 | Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation. | Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40327333 | PubMed |
| 12 | 35439677 | Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis. | EBioMedicine | 2022 | https://conductscience.org/library/papers/35439677 | PubMed |
| 13 | 40429755 | Ovarian Cancer-Epidemiology, Classification, Pathogenesis, Treatment, and Estrogen Receptors' Molecular Backgrounds. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40429755 | PubMed |
| 14 | 40690248 | Ovarian Cancer: A Review. | JAMA | 2025 | https://conductscience.org/library/papers/40690248 | PubMed |
| 15 | 38754054 | Global Incidence of Ovarian Cancer According to Histologic Subtype: A Population-Based Cancer Registry Study. | JCO Glob Oncol | 2024 | https://conductscience.org/library/papers/38754054 | PubMed |
| 16 | 38548868 | Global epidemiology of epithelial ovarian cancer. | Nat Rev Clin Oncol | 2024 | https://conductscience.org/library/papers/38548868 | PubMed |
| 17 | 28931370 | Association between tumour infiltrating lymphocytes, histotype and clinical outcome in epithelial ovarian cancer. | BMC Cancer | 2017 | https://conductscience.org/library/papers/28931370 | PubMed |
| 18 | 22863523 | Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies. | Lancet Oncol | 2012 | https://conductscience.org/library/papers/22863523 | PubMed |
| 19 | 22711857 | BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22711857 | PubMed |
| 20 | 29809280 | Ovarian cancer statistics, 2018. | CA Cancer J Clin | 2018 | https://conductscience.org/library/papers/29809280 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41454273
GET https://conductscience.org/api/papers/v1/41454273/references?page=2